Question 1: (20 marks online) Rosiglitazone has been implicated in major risk increase of specific cardiovascular events. The product has been withdrawn from various international markets due to concerns about its safety profile. In the United States of America, the Food and Drug Administration (FDA) decided to restrict the use of rosiglitazone to patients with Type II diabetes who cannot control their diabetes with other […]